info:eu-repo/semantics/article
Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase
Fecha
2012Institución
Resumen
Pyrazinamidase of Mycobacterium tuberculosis catalyzes the conversion of pyrazinamide to the active molecule pyrazinoic acid. Reduction of pyrazinamidase activity results in a level of pyrazinamide resistance. Previous studies have suggested that pyrazinamidase has a metal-binding site and that a divalent metal cofactor is required for activity. To determine the effect of divalent metals on the pyrazinamidase, the recombinant wild-type pyrazinamidase corresponding to the H37Rv pyrazinamide-susceptible reference strain was expressed in Escherichia coli with and without a carboxy terminal. His-tagged pyrazinamidase was inactivated by metal depletion and reactivated by titration with divalent metals. Although Co2+, Mn2+, and Zn2+ restored pyrazinamidase activity, only Co2+ enhanced the enzymatic activity to levels higher than the wild-type pyrazinamidase. Cu2+, Fe 2+, Fe3+, and Mg2+ did not restore the activity under the conditions tested. Various recombinant mutated pyrazinamidases with appropriate folding but different enzymatic activities showed a differential pattern of recovered activity. X-ray fluorescence and atomic absorbance spectroscopy showed that recombinant wild-type pyrazinamidase expressed in E. coli most likely contained Zn. In conclusion, this study suggests that M. tuberculosis pyrazinamidase is a metalloenzyme that is able to coordinate several ions, but in vivo, it is more likely to coordinate Zn2+. However, in vitro, the metal-depleted enzyme could be reactivated by several divalent metals with higher efficiency than Zn.
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Chorismate synthase: An attractive target for drug development against orphan diseases
Dias, Marcio V.B.; Ely, Fernanda; Palma, Mario Sergio; Azevedo Jr., Walter F. de; Basso, Luiz A.; Santos, Diógenes S. -
Chorismate synthase: An attractive target for drug development against orphan diseases
Universidade Estadual Paulista (Unesp); Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) (2007-03-01)The increase in incidence of infectious diseases worldwide, particularly in developing countries, is worrying. Each year, 14 million people are killed by infectious diseases, mainly HIV/AIDS, respiratory infections, malaria ... -
Chorismate synthase: An attractive target for drug development against orphan diseases
Universidade Estadual Paulista (Unesp); Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) (2007-03-01)The increase in incidence of infectious diseases worldwide, particularly in developing countries, is worrying. Each year, 14 million people are killed by infectious diseases, mainly HIV/AIDS, respiratory infections, malaria ...